Other Science
476 articles
Patients Needed for Clinical Trial/Research Study of Treatment Targeting Immune System
A clinical trial seeks pancreatic cancer patients with the MSI (microsatellite instability) genetic signature, to test an immunotherapy drug.
How COVID-19 Is Transmitted: The Latest Information
Virus in the air? Asymptomatic carriers? Surfaces? Pets? Find out the latest information about how COVID-19 is transmitted.
Where We Are with COVID-19—A Wrap-Up
In a final COVID-19 Tip of the Week, pancreatic cancer patients need to continue social distancing, wearing masks, and washing hands frequently.
Practical Tips For Patients In Treatment
Long-term survivor and patient advocate Steven Merlin has a host of practical tips for patients to help manage life during treatment.
Let’s Learn Webinar on Symptoms on March 25th
Are you a health care professional who wants to know more about the risks, symptoms, and treatments for pancreatic cancer? Join our Symptoms webinar to learn more!
A New Approach to Overcome Drug Resistance
Dr. Despina Siolas is leading one of the sites where a new drug combination to combat the effects of KRAS mutations is under trial.
Putting Familial Risk In Perspective
Dr. Alison Klein works to understand the relationship between familial risk and the chances of developing pancreatic cancer.
Traveling with Pancreatic Cancer
Drs. Sunil Hingorani and David Zhen outline the ways to make traveling with pancreatic cancer easier if you are in treatment.
AVENGER 500 Clinical Trial Shows No Overall Survival Benefit
Data from the AVENGER 500 clinical trial explains why the trial’s goal was not met. A new trial with a different approach has launched.
Advocacy Organizations Make a Difference
Learn more about advocacy organizations the Griffith Family Foundation, Rolfe Foundation, and Scott Eli Jackson Foundation., and how each helps pancreatic cancer patients and families.
Chemo Before Surgery Doubles Overall Survival in Some Patients
Dr. Marco Del Chiaro explains the results of an international study of outcomes for patients who had neoadjuvant treatment before surgery.